BERLIN--(BUSINESS WIRE)--Contract Research Organization (CRO), KCR, which operates across 19 European countries as well as the U.S., announced today that it is relocating its head office from Warsaw, Poland, to Berlin, Germany. The new location is supposed to better serve its own customers and support the company’s expanding services and operations.
“This is an important step to further implement KCR’s business growth strategy,” stated Mike Jagielski, President & CEO of KCR. “The establishment of a new head office in Berlin builds upon our previous decisions on strengthening the company’s footprint in Western Europe. Moving to Germany is a response to our clients’ expectations regarding KCR’s strong presence in Western Europe. It will also allow us to further diversify the KCR talent pool to support our customer focused approach.”
The head office in Berlin will serve as a management and business development center, whereas the office in Warsaw will continue to be the company’s operational hub. KCR European coverage includes entities in Western Europe in Austria, France and the UK as well as in Central and Eastern Europe (CEE) and the Commonwealth of Independent States (CIS). Due to the project portfolio acquisition of Ukrainian CRO Axis, KCR has recently become one of the key players for trial execution in Ukraine.
“KCR continues to expand and enhance its capacities to provide our clients with successful, high-quality clinical development services. We believe that our new head office in Berlin will successfully corroborate our planned growth strategy for the years to come,” summarized Mr. Jagielski.
KCR’s new Berlin office is located in Mitte, the historical center of German capital, in Pergamon Palais, Am Kupfergraben 4-4a, DE-10117 Berlin. To view all KCR locations, please click here.
If you would like to learn more about KCR services, please contact Joanna Lewandowska, PR & Marketing Manager, at firstname.lastname@example.org. Please include your full contact details in the query.
KCR is a Contract Research Organization (CRO) operating across 19 countries in Europe as well as the U.S. The company is a strategic solutions provider for pharmaceutical and biotechnology firms who are looking for a reliable alternative to top tier CROs. Over 300 professionals offer full service capabilities in three main product lines: Trial Execution, Functional Service Provision (FSP) and Late Phase, across a wide range of therapeutic areas. Focusing on knowledge, quality and innovation, KCR and its services supports 12 of the Top 20 Global Pharma companies, as well as biotech firms from Europe, Israel and the U.S. on long standing contracts. For more information please visit: www.kcrcro.com.
KCR: We see human behind every number.